Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kemp

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Journal of Food Protection|August 17, 2000
Acidified sodium chlorite antimicrobial treatment of broiler carcassesG K Kemp, M L Aldrich, A L Waldroup
Drugs|August 28, 2016
Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart FailureBarbara K Kemp-Harper, John D Horowitz, Rebecca H Ritchie
British Journal of Pharmacology|May 31, 2018
Inflammasomes: a novel therapeutic target in pulmonary hypertension?Tara Elizabeth Scott, Barbara K Kemp-Harper, Adrian J Hobbs
Hypertension (Dallas, Tex. : 1979)|May 14, 2003
NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteriesJennifer C Irvine, Joanne L Favaloro, Barbara K Kemp-Harper
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 17, 2001
Cloning, expression and antigenicity of the L. donovani reductaseA T Jensen, K Kemp, T G Theander, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart diseaseLinda K Kemp, Christopher M Doran, Theo Vos, et al.
Antioxidants & Redox Signaling|September 21, 2010
Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NOJennifer C Irvine, Barbara K Kemp-Harper, Robert E Widdop
Lancet (London, England)|March 18, 1989
Carbamazepine for cocaine addiction?J Halikas, K Kemp, K Kuhn, et al.
Public Health Reports (Washington, D.C. : 1974)|November 1, 1981
Factors affecting the use of vaccines: considerations for immunization program plannersM A Riddiough, J S Willems, C R Sanders, et al.
Lipids|October 1, 1989
Effects of dietary fats on fatty acid composition and delta 5 desaturase in normal and diabetic ratsA Q Dang, K Kemp, F H Faas, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Journal of Food Protection|August 17, 2000
Acidified sodium chlorite antimicrobial treatment of broiler carcassesG K Kemp, M L Aldrich, A L Waldroup
Drugs|August 28, 2016
Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart FailureBarbara K Kemp-Harper, John D Horowitz, Rebecca H Ritchie
British Journal of Pharmacology|May 31, 2018
Inflammasomes: a novel therapeutic target in pulmonary hypertension?Tara Elizabeth Scott, Barbara K Kemp-Harper, Adrian J Hobbs
Hypertension (Dallas, Tex. : 1979)|May 14, 2003
NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteriesJennifer C Irvine, Joanne L Favaloro, Barbara K Kemp-Harper
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 17, 2001
Cloning, expression and antigenicity of the L. donovani reductaseA T Jensen, K Kemp, T G Theander, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart diseaseLinda K Kemp, Christopher M Doran, Theo Vos, et al.
Antioxidants & Redox Signaling|September 21, 2010
Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NOJennifer C Irvine, Barbara K Kemp-Harper, Robert E Widdop
Lancet (London, England)|March 18, 1989
Carbamazepine for cocaine addiction?J Halikas, K Kemp, K Kuhn, et al.
Public Health Reports (Washington, D.C. : 1974)|November 1, 1981
Factors affecting the use of vaccines: considerations for immunization program plannersM A Riddiough, J S Willems, C R Sanders, et al.
Lipids|October 1, 1989
Effects of dietary fats on fatty acid composition and delta 5 desaturase in normal and diabetic ratsA Q Dang, K Kemp, F H Faas, et al.
Pageof 18